在6小时内MR导向输液成像不匹配资料对内血管血栓切除术结果的影响
Xiaohui Li1, Zhaomin Lu1, Shuo Li1
1Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
概括
在急性缺血性中风症状出现后6小时内,磁共振引导的输液成像有助于预测结果. 更大的输液加权成像/扩散加权成像不匹配与内血管血栓切除术后更好的临床结果有关.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 医疗成像医学成像
背景情况:
- 急性缺血性中风 (AIS) 的治疗重点是早期的再输血.
- 早期半阴影成像对AIS结果的影响尚未完全理解.
- 这项研究研究了在6小时内对接受内血管血栓切除术的AIS患者进行MR导向输液成像.
研究的目的:
- 为了确定MR导向输液成像在6小时内对AIS患者内血管内血栓切除术结果的影响.
- 评估输液加权成像/扩散加权成像 (PWI/DWI) 对临床结果不匹配的预测价值.
主要方法:
- 在AISRNA和EVTRNA研究中从AIS患者收集临床数据的前性收集.
- 血管内血栓切除术根据MR引导的输液成像在症状出现后6小时内进行.
- 主要结局:不良结局 (修改后的兰金级评分>2在90天).
- 用于PWI/DWI不匹配评估的自动化软件.
主要成果:
- 分析了84名患者:25人不匹配 ≤1.8组,59人不匹配>1.8组.
- 在不匹配 ≤ 1.8 组中,残疾性中风的发病率较高 (mRS > 2) (68.0%对比 40.7%).
- 在不匹配>1.8组中,内出血和严重脑的发生率显著降低.
- 经过调整后,调查结果仍然很重要.
结论:
- 在6小时内,MRI导向输液成像不匹配配置文件可以预测AIS的临床结果.
- 这种成像方法可能有助于减少内血管血栓切除术后临床无效的再输血.
- PWI/DWI不匹配评估有助于优化AIS患者的治疗决策.
相关概念视频
Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Holter Monitor: 24-Hour Monitoring
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...


